Source: International Journal of Nanomedicine. Unidade: FFCLRP
Subjects: FUNGICIDAS, FARMACOCINÉTICA, LEISHMANIA BRASILIENSIS, LEISHMANIOSE CUTÂNEA, FARMACOTERAPIA, MACRÓFAGOS
ABNT
REBOUÇAS-SILVA, Jéssica et al. Evaluation of in vitro and in vivo efficacy of a novel amphotericin B-loaded nanostructured lipid carrier in the treatment of Leishmania braziliensis infection. International Journal of Nanomedicine, v. 15, p. 8659-8672, 2020Tradução . . Disponível em: https://doi.org/10.2147/IJN.S262642. Acesso em: 04 nov. 2024.APA
Rebouças-Silva, J., Tadini, M. C., Devequi-Nunes, D., Mansur, A. L., Silveira-Mattos, P. S., Oliveira, C. I. de, et al. (2020). Evaluation of in vitro and in vivo efficacy of a novel amphotericin B-loaded nanostructured lipid carrier in the treatment of Leishmania braziliensis infection. International Journal of Nanomedicine, 15, 8659-8672. doi:10.2147/IJN.S262642NLM
Rebouças-Silva J, Tadini MC, Devequi-Nunes D, Mansur AL, Silveira-Mattos PS, Oliveira CI de, Formiga FR, Berretta AA, Marquele-Oliveira F, Borges VM. Evaluation of in vitro and in vivo efficacy of a novel amphotericin B-loaded nanostructured lipid carrier in the treatment of Leishmania braziliensis infection [Internet]. International Journal of Nanomedicine. 2020 ; 15 8659-8672.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2147/IJN.S262642Vancouver
Rebouças-Silva J, Tadini MC, Devequi-Nunes D, Mansur AL, Silveira-Mattos PS, Oliveira CI de, Formiga FR, Berretta AA, Marquele-Oliveira F, Borges VM. Evaluation of in vitro and in vivo efficacy of a novel amphotericin B-loaded nanostructured lipid carrier in the treatment of Leishmania braziliensis infection [Internet]. International Journal of Nanomedicine. 2020 ; 15 8659-8672.[citado 2024 nov. 04 ] Available from: https://doi.org/10.2147/IJN.S262642